Skip to main content
SpringerLink
Log in

Cardiac PET Imaging: Principles and New Developments

  • Chapter
  • First Online:
Basic Science of PET Imaging

Abstract

A growing interest in cardiac physiology, disease, and treatment has fuelled the development of cardiac PET applications both for research and clinical use. Imaging of the heart poses unique challenges, including the presence of cardiac, respiratory, and organ motions and complex anatomy. As with other organs, common challenges include physiologic interactions from the systematic level down to the molecular level and a broad range of diseases. Since cardiology includes mechanical, electrical, blood flow, metabolic, neurohormonal, immunological, and genetic aspects, cardiac imaging is a broad field with a wide range of tracers and applications designed to probe all of these mechanisms. This chapter provides an overview of existing applications and recent developments of cardiac PET imaging.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Dilsizian V, Bacharach SL, Beanlands RS, Bergmann SR, Delbeke D, Gropler RJ, Knuuti J, Schelbert HR, Travin MI. PET myocardial perfusion and metabolism clinical imaging. J Nucl Cardiol. 2009;16(4):651.

    Google Scholar 

  2. Burns M. The market for PET radiopharmaceuticals & PET imaging. BIO-Tech Systems, Inc. 2014;370.

    Google Scholar 

  3. Cherry SR, Sorenson JA, Phelps ME. Physics in nuclear medicine. 4th ed. Philadelphia: Elsevier/Saunders; 2012.

    Google Scholar 

  4. Klein R, Beanlands RSB, deKemp RA. Quantification of myocardial blood flow and flow reserve: technical aspects. J Nucl Cardiol. 2010;17(4):555–70.

    Article  PubMed  Google Scholar 

  5. Huang C, Petibon Y, Ouyang J, Reese TG, Ahlman MA, Bluemke DA, El Fakhri G. Accelerated acquisition of tagged MRI for cardiac motion correction in simultaneous PET-MR: phantom and patient studies. Med Phys. 2015;42(2):1087–97.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Ratib O, Nkoulou N. Potential applications of PET/MR imaging in cardiology. J Nucl Med Off Publ Soc Nucl Med. 2014;55 Suppl 2:40S–6.

    Google Scholar 

  7. Iqbal B, Currie G, Greene L, Kiat H. Novel radiopharmaceuticals in cardiovascular medicine: present and future. J Med Imaging Radiat Sci. 2014;45(4):423–34.

    Article  Google Scholar 

  8. Bengel FM, Higuchi T, Javadi MS, Lautamäki R. Cardiac positron emission tomography. J Am Coll Cardiol. 2009;54(1):1–15.

    Article  PubMed  Google Scholar 

  9. Massoud TF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev. 2003;17(5):545–80.

    Article  CAS  PubMed  Google Scholar 

  10. Welling MM, Duijvestein M, Signore A, van der Weerd L. In vivo biodistribution of stem cells using molecular nuclear medicine imaging. J Cell Physiol. 2011;226(6):1444–52.

    Article  CAS  PubMed  Google Scholar 

  11. Members C, Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, O’Gara PT, Carabello BA, Russell RO, Cerqueira MD, Sutton MGSJ, DeMaria AN, Udelson JE, Kennedy JW, Verani MS, Williams KA, Antman EM, Smith SC, Alpert JS, Gregoratos G, Anderson JL, Hiratzka LF, Faxon DP, Hunt SA, Fuster V, Jacobs AK, Gibbons RJ, Russell RO. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging. Circulation. 2003;108(11):1404–18.

    Article  Google Scholar 

  12. Loong CY, Anagnostopoulos C. Diagnosis of coronary artery disease by radionuclide myocardial perfusion imaging. Heart. 2004;90 Suppl 5:v2–9.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Bateman T, Heller G, Mcghie A, Friedman J, Case J, Bryngelson J, Hertenstein G, Moutray K, Reid K, Cullom S. Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: comparison with ECG-gated Tc-99m sestamibi SPECT. J Nucl Cardiol. 2006;13(1):24–33.

    Article  PubMed  Google Scholar 

  14. Hachamovitch R, Rozanski A, Shaw LJ, Stone GW, Thomson LEJ, Friedman JD, Hayes SW, Cohen I, Germano G, Berman DS. Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy. Eur Heart J. 2011;32(8):1012–24.

    Article  PubMed  Google Scholar 

  15. Yoshinaga K, Chow BJW, Williams K, Chen L, deKemp RA, Garrard L, Lok-Tin Szeto A, Aung M, Davies RA, Ruddy TD, Beanlands RSB. What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography? J Am Coll Cardiol. 2006;48(5):1029–39.

    Article  PubMed  Google Scholar 

  16. Mc Ardle BA, Dowsley TF, deKemp RA, Wells GA, Beanlands RS. Does rubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosis of obstructive coronary disease? J Am Coll Cardiol. 2012;60(18):1828–37.

    Article  PubMed  Google Scholar 

  17. Merhige ME, Breen WJ, Shelton V, Houston T, D’Arcy BJ, Perna AF. Impact of myocardial perfusion imaging with PET and 82Rb on downstream invasive procedure utilization, costs, and outcomes in coronary disease management. J Nucl Med. 2007;48(7):1069–76.

    Article  PubMed  Google Scholar 

  18. Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, Mark DB, McCallister BD, Mooss AN, O’Reilly MG, Winters WL, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Hiratzka LF, Jacobs AK, Russell RO, Smith SC. ACC/AHA 2002 guideline update for exercise testing: summary article a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation. 2002;106(14):1883–92.

    Article  PubMed  Google Scholar 

  19. Dilsizian V, Bacharach SL, Beanlands RS, Bergmann SR, Delbeke D, Dorbala S, Gropler RJ, Knuuti J, Schelbert HR, Travin MI. ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures. J Nucl Cardiol. 2016. [Epub ahead of print].

    Google Scholar 

  20. Yoshinaga K, Katoh C, Manabe O, Klein R, Naya M, Sakakibara M, Yamada S, deKemp RA, Tsutsui H, Tamaki N. Incremental diagnostic value of regional myocardial blood flow quantification over relative perfusion imaging with generator-produced rubidium-82 PET. Circ J. 2011;75(11):2628–34.

    Article  PubMed  Google Scholar 

  21. Naya M, Morita K, Yoshinaga K, Manabe O, Goto D, Hirata K, Katoh C, Tamaki N, Tsutsui H. Long-term smoking causes more advanced coronary endothelial dysfunction in middle-aged smokers compared to young smokers. Eur J Nucl Med Mol Imaging. 2011;38(3):491–8.

    Article  PubMed  Google Scholar 

  22. Lynch F, Sweeney M, O’Regan RG, McLoughlin P. Hypercapnia-induced contraction in isolated pulmonary arteries is endothelium-dependent. Respir Physiol. 2000;121(1):65–74.

    Article  CAS  PubMed  Google Scholar 

  23. Croteau E, Renaud JM, Archer C, Klein R, DaSilva JN, Ruddy TD, Beanlands RS, deKemp RA. β2-adrenergic stress evaluation of coronary endothelial-dependent vasodilator function in mice using 11C-acetate micro-PET imaging of myocardial blood flow and oxidative metabolism. EJNMMI Res. 2014;4(1):68.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Holly TA, Abbott BG, Al-Mallah M, Calnon DA, Cohen MC, DiFilippo FP, Ficaro EP, Freeman MR, Hendel RC, Jain D, Leonard SM, Nichols KJ, Polk DM, Soman P. Single photon-emission computed tomography. J Nucl Cardiol. 2010;17(5):941–73.

    Article  PubMed  Google Scholar 

  25. Knollmann D, Knebel I, Koch K-C, Gebhard M, Krohn T, Buell U, Schaefer WM. Comparison of SSS and SRS calculated from normal databases provided by QPS and 4D-MSPECT manufacturers and from identical institutional normals. Eur J Nucl Med Mol Imaging. 2008;35(2):311–8.

    Article  PubMed  Google Scholar 

  26. Slomka PJ, Nishina H, Berman DS, Akincioglu C, Abidov A, Friedman JD, Hayes SW, Germano G. Automated quantification of myocardial perfusion SPECT using simplified normal limits. J Nucl Cardiol Off Publ Am Soc Nucl Cardiol. 2005;12(1):66–77.

    Article  Google Scholar 

  27. Parkash R, deKemp RA, Ruddy TD, Kitsikis A, Hart R, Beauschene L, Williams K, Davies RA, Labinaz M, Beanlands RSB. Potential utility of rubidium 82 pet quantification in patients with 3-vessel coronary artery disease. J Nucl Cardiol. 2004;11(4):440–9.

    Article  CAS  PubMed  Google Scholar 

  28. Ziadi MC, Beanlands RSB. The clinical utility of assessing myocardial blood flow using positron emission tomography. J Nucl Cardiol. 2010;17(4):571–81.

    Article  PubMed  Google Scholar 

  29. Ziadi MC, deKemp RA, Williams KA, Guo A, Chow BJW, Renaud JM, Ruddy TD, Sarveswaran N, Tee RE, Beanlands RSB. Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. J Am Coll Cardiol. 2011;58(7):740–8.

    Article  PubMed  Google Scholar 

  30. Dayanikli F, Grambow D, Muzik O, Mosca L, Rubenfire M, Schwaiger M. Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography. Circulation. 1994;90(2):808–17.

    Article  CAS  PubMed  Google Scholar 

  31. Johnson NP, Gould KL. Physiological basis for angina and ST-segment change. JACC Cardiovasc Imaging. 2011;4(9):990–8.

    Article  PubMed  Google Scholar 

  32. Johnson NP, Gould KL. Integrating noninvasive absolute flow, coronary flow reserve, and ischemic thresholds into a comprehensive map of physiological severity. JACC Cardiovasc Imaging. 2012;5(4):430–40.

    Article  PubMed  Google Scholar 

  33. Lortie M, Beanlands RSB, Yoshinaga K, Klein R, DaSilva JN, deKemp RA. Quantification of myocardial blood flow with 82Rb dynamic PET imaging. Eur J Nucl Med Mol Imaging. 2007;34(11):1765–74.

    Article  PubMed  Google Scholar 

  34. Johnson NP, Kirkeeide RL, Gould KL. Is discordance of coronary flow reserve and fractional flow reserve due to methodology or clinically relevant coronary pathophysiology? JACC Cardiovasc Imaging. 2012;5(2):193–202.

    Article  PubMed  Google Scholar 

  35. Pijls NHJ, Fearon WF, Tonino PAL, Siebert U, Ikeno F, Bornschein B, van’t Veer M, Klauss V, Manoharan G, Engstrøm T, Oldroyd KG, Ver Lee PN, MacCarthy PA, De Bruyne B. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease. J Am Coll Cardiol. 2010;56(3):177–84.

    Article  PubMed  Google Scholar 

  36. Kini AS, Kim MC, Moreno PR, Krishnan P, Ivan OC, Sharma SK. Comparison of coronary flow reserve and fractional flow reserve in patients with versus without diabetes mellitus and having elective percutaneous coronary intervention and abciximab therapy (from the PREDICT Trial). Am J Cardiol. 2008;101(6):796–800.

    Article  PubMed  Google Scholar 

  37. Nesterov SV, Han C, Mäki M, Kajander S, Naum AG, Helenius H, Lisinen I, Ukkonen H, Pietilä M, Joutsiniemi E, Knuuti J. Myocardial perfusion quantitation with 15O-labelled water PET: high reproducibility of the new cardiac analysis software (CarimasTM). Eur J Nucl Med Mol Imaging. 2009;36(10):1594–602.

    Article  PubMed  Google Scholar 

  38. Bengel FM. Leaving relativity behind. J Am Coll Cardiol. 2011;58(7):749–51.

    Article  PubMed  Google Scholar 

  39. Klein R. Editorial: derivation of respiratory gating signals from ECG signals. J Nucl Cardiol. 2015;23(1):84–6.

    Article  PubMed  Google Scholar 

  40. Hunter CRRN, Hill J, Ziadi MC, Beanlands RSB, deKemp RA. Biodistribution and radiation dosimetry of (82)Rb at rest and during peak pharmacological stress in patients referred for myocardial perfusion imaging. Eur J Nucl Med Mol Imaging. 2015;42(7):1032–42.

    Article  CAS  PubMed  Google Scholar 

  41. Packard RRS, Huang S-C, Dahlbom M, Czernin J, Maddahi J. Absolute quantitation of myocardial blood flow in human subjects with or without myocardial ischemia using dynamic flurpiridaz F 18 PET. J Nucl Med. 2014;55(9):1438–44.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Schelbert HR. Current status and prospects of new radionuclides and radiopharmaceuticals for cardiovascular nuclear medicine. Semin Nucl Med. 1987;17(2):145–81.

    Article  CAS  PubMed  Google Scholar 

  43. Yoshida K, Mullani N, Gould KL. Coronary flow and flow reserve by PET simplified for clinical applications using rubidium-82 or nitrogen-13-ammonia. J Nucl Med. 1996;37(10):1701–12.

    CAS  PubMed  Google Scholar 

  44. deKemp RA, Declerck J, Klein R, Pan X-B, Nakazato R, Tonge C, Arumugam P, Berman DS, Germano G, Beanlands RS, Slomka PJ. Multisoftware reproducibility study of stress and rest myocardial blood flow assessed with 3D dynamic PET/CT and a 1-tissue-compartment model of 82Rb kinetics. J Nucl Med. 2013;54(4):571–7.

    Article  CAS  PubMed  Google Scholar 

  45. Tahari AK, Lee A, Rajaram M, Fukushima K, Lodge MA, Lee BC, Ficaro EP, Nekolla S, Klein R, deKemp RA, Wahl RL, Bengel FM, Bravo PE. Absolute myocardial flow quantification with 82Rb PET/CT: comparison of different software packages and methods. Eur J Nucl Med Mol Imaging. 2014;41(1):126–35.

    Article  PubMed  Google Scholar 

  46. Klingensmith WC, Noonan C, Goldberg JH, Buchwald D, Kimball JT, Manson SM. Decreased perfusion in the lateral wall of the left ventricle in PET/CT studies with 13N-ammonia: evaluation in healthy adults. J Nucl Med Technol. 2009;37(4):215–9.

    Article  PubMed  Google Scholar 

  47. Maddahi J, Czernin J, Lazewatsky J, Huang S-C, Dahlbom M, Schelbert H, Sparks R, Ehlgen A, Crane P, Zhu Q, Devine M, Phelps M. Phase I, first-in-human study of BMS747158, a novel 18F-labeled tracer for myocardial perfusion PET: dosimetry, biodistribution, safety, and imaging characteristics after a single injection at rest. J Nucl Med. 2011;52(9):1490–8.

    Article  CAS  PubMed  Google Scholar 

  48. Giedd KN, Bergmann SR. Fatty acid imaging of the heart. Curr Cardiol Rep. 2011;13(2):121–31.

    Article  PubMed  Google Scholar 

  49. Tahara N, Mukherjee J, de Haas HJ, Petrov AD, Tawakol A, Haider N, Tahara A, Constantinescu CC, Zhou J, Boersma HH, Imaizumi T, Nakano M, Finn A, Fayad Z, Virmani R, Fuster V, Bosca L, Narula J. 2-deoxy-2-[18F]fluoro-d-mannose positron emission tomography imaging in atherosclerosis. Nat Med. 2014;20(2):215–9.

    Article  CAS  PubMed  Google Scholar 

  50. Panneerselvam K, Freeze HH. Mannose enters mammalian cells using a specific transporter that is insensitive to glucose. J Biol Chem. 1996;271(16):9417–21.

    Article  CAS  PubMed  Google Scholar 

  51. Herrero P, Dence CS, Coggan AR, Kisrieva-Ware Z, Eisenbeis P, Gropler RJ. l-3-11C-lactate as a PET tracer of myocardial lactate metabolism: a feasibility study. J Nucl Med. 2007;48(12):2046–55.

    Article  CAS  PubMed  Google Scholar 

  52. Renstrom B, Rommelfanger S, Stone CK, DeGrado TR, Carlson KJ, Scarbrough E, Nickles RJ, Liedtke AJ, Holden JE. Comparison of fatty acid tracers FTHA and BMIPP during myocardial ischemia and hypoxia. J Nucl Med Off Publ Soc Nucl Med. 1998;39(10):1684–9.

    CAS  Google Scholar 

  53. DeGrado TR, Kitapci MT, Wang S, Ying J, Lopaschuk GD. Validation of 18F-fluoro-4-thia-palmitate as a PET probe for myocardial fatty acid oxidation: effects of hypoxia and composition of exogenous fatty acids. J Nucl Med Off Publ Soc Nucl Med. 2006;47(1):173–81.

    CAS  Google Scholar 

  54. Shoup TM, Elmaleh DR, Bonab AA, Fischman AJ. Evaluation of trans-9-18F-fluoro-3,4-Methyleneheptadecanoic acid as a PET tracer for myocardial fatty acid imaging. J Nucl Med Off Publ Soc Nucl Med. 2005;46(2):297–304.

    CAS  Google Scholar 

  55. Peterson LR, Gropler RJ. Radionuclide imaging of myocardial metabolism. Circ Cardiovasc Imaging. 2010;3(2):211–22.

    Article  PubMed  Google Scholar 

  56. Mc Ardle BA, Beanlands RSB. Myocardial viability: whom, what, why, which, and how? Can J Cardiol. 2013;29(3):399–402.

    Article  PubMed  Google Scholar 

  57. D’Egidio G, Nichol G, Williams KA, Guo A, Garrard L, deKemp R, Ruddy TD, DaSilva J, Humen D, Gulenchyn KY, Freeman M, Racine N, Benard F, Hendry P, Beanlands RSB, PARR-2 Investigators. Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial. JACC Cardiovasc Imaging. 2009;2(9):1060–8.

    Article  PubMed  Google Scholar 

  58. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002;39(7):1151–8.

    Article  PubMed  Google Scholar 

  59. Rohatgi R, Epstein S, Henriquez J, Ababneh AA, Hickey KT, Pinsky D, Akinboboye O, Bergmann SR. Utility of positron emission tomography in predicting cardiac events and survival in patients with coronary artery disease and severe left ventricular dysfunction. Am J Cardiol. 2001;87(9):1096–99, A6.

    Article  CAS  PubMed  Google Scholar 

  60. Di Carli MF, Davidson M, Little R, Khanna S, Mody FV, Brunken RC, Czernin J, Rokhsar S, Stevenson LW, Laks H. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol. 1994;73(8):527–33.

    Article  PubMed  Google Scholar 

  61. Eitzman D, al-Aouar Z, Kanter HL, vom Dahl J, Kirsh M, Deeb GM, Schwaiger M. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol. 1992;20(3):559–65.

    Article  CAS  PubMed  Google Scholar 

  62. Beanlands RSB, Nichol G, Huszti E, Humen D, Racine N, Freeman M, Gulenchyn KY, Garrard L, deKemp R, Guo A, Ruddy TD, Benard F, Lamy A, Iwanochko RM, PARR-2 Investigators. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). J Am Coll Cardiol. 2007;50(20):2002–12.

    Article  PubMed  Google Scholar 

  63. Abraham A, Nichol G, Williams KA, Guo A, deKemp RA, Garrard L, Davies RA, Duchesne L, Haddad H, Chow B, DaSilva J, Beanlands RSB, for the P. 2 Investigators. 18F-FDG PET imaging of myocardial viability in an experienced center with access to 18F-FDG and integration with clinical management teams: the Ottawa-FIVE substudy of the PARR 2 trial. J Nucl Med. 2010;51(4):567–74.

    Article  PubMed  Google Scholar 

  64. Dilsizian V, Bateman TM, Bergmann SR, Prez RD, Magram MY, Goodbody AE, Babich JW, Udelson JE. Metabolic imaging with β-methyl-p-[123I]-iodophenyl-pentadecanoic acid identifies ischemic memory after demand ischemia. Circulation. 2005;112(14):2169–74.

    Article  PubMed  Google Scholar 

  65. Inaba Y, Bergmann SR. Prognostic value of myocardial metabolic imaging with BMIPP in the spectrum of coronary artery disease: a systematic review. J Nucl Cardiol Off Publ Am Soc Nucl Cardiol. 2010;17(1):61–70.

    Article  Google Scholar 

  66. Watabe H, Ikoma Y, Kimura Y, Naganawa M, Shidahara M. PET kinetic analysis – compartmental model. Ann Nucl Med. 2006;20(9):583–8.

    Article  CAS  PubMed  Google Scholar 

  67. Hutchins GD, Caraher JM, Raylman RR. A region of interest strategy for minimizing resolution distortions in quantitative myocardial PET studies. J Nucl Med Off Publ Soc Nucl Med. 1992;33(6):1243–50.

    CAS  Google Scholar 

  68. Gambhir SS, Schwaiger M, Huang SC, Krivokapich J, Schelbert HR, Nienaber CA, Phelps ME. Simple noninvasive quantification method for measuring myocardial glucose utilization in humans employing positron emission tomography and fluorine-18 deoxyglucose. J Nucl Med Off Publ Soc Nucl Med. 1989;30(3):359–66.

    CAS  Google Scholar 

  69. Bøtker HE, Böttcher M, Schmitz O, Gee A, Hansen SB, Cold GE, Nielsen TT, Gjedde A. Glucose uptake and lumped constant variability in normal human hearts determined with [18F]fluorodeoxyglucose. J Nucl Cardiol. 1997;4(2):125–32.

    Article  PubMed  Google Scholar 

  70. Youssef G, Leung E, Mylonas I, Nery P, Williams K, Wisenberg G, Gulenchyn KY, Dekemp RA, Dasilva J, Birnie D, Wells GA, Beanlands RSB. The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience. J Nucl Med. 2012;53(2):241–8.

    Google Scholar 

  71. Rudd JHF, Narula J, Strauss HW, Virmani R, Machac J, Klimas M, Tahara N, Fuster V, Warburton EA, Fayad ZA, Tawakol AA. Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography. J Am Coll Cardiol. 2010;55(23):2527–35.

    Article  PubMed  Google Scholar 

  72. Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med. 1997;336(18):1276–82.

    Google Scholar 

  73. Cocker MS, Mc Ardle B, Spence JD, Lum C, Hammond RR, Ongaro DC, McDonald MA, deKemp RA, Tardif J-C, Beanlands RSB. Imaging atherosclerosis with hybrid [18F]fluorodeoxyglucose positron emission tomography/computed tomography imaging: what Leonardo da Vinci could not see. J Nucl Cardiol. 2012;19(6):1211–25.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Arauz A, Hoyos L, Zenteno M, Mendoza R, Alexanderson E. Carotid plaque inflammation detected by 18F-fluorodeoxyglucose-positron emission tomography: pilot study. Clin Neurol Neurosurg. 2007;109(5):409–12.

    Article  PubMed  Google Scholar 

  75. Paulmier B, Duet M, Khayat R, Pierquet-Ghazzar N, Laissy J-P, Maunoury C, Hugonnet F, Sauvaget E, Trinquart L, Faraggi M. Arterial wall uptake of fluorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events. J Nucl Cardiol Off Publ Am Soc Nucl Cardiol. 2008;15(2):209–17.

    Article  Google Scholar 

  76. Moustafa RR, Izquierdo-Garcia D, Fryer TD, Graves MJ, Rudd JHF, Gillard JH, Weissberg PL, Baron J-C, Warburton EA. Carotid plaque inflammation is associated with cerebral microembolism in patients with recent transient ischemic attack or stroke a pilot study. Circ Cardiovasc Imaging. 2010;3(5):536–41.

    Article  PubMed  Google Scholar 

  77. Grandpierre S, Desandes E, Meneroux B, Djaballah W, Mandry D, Netter F, Wahl D, Fay R, Karcher G, Marie P-Y. Arterial foci of F-18 fluorodeoxyglucose are associated with an enhanced risk of subsequent ischemic stroke in cancer patients: a case–control pilot study. Clin Nucl Med. 2011;36(2):85–90.

    Article  PubMed  Google Scholar 

  78. Joshi NV, Vesey AT, Williams MC, Shah ASV, Calvert PA, Craighead FHM, Yeoh SE, Wallace W, Salter D, Fletcher AM, van Beek EJR, Flapan AD, Uren NG, Behan MWH, Cruden NLM, Mills NL, Fox KAA, Rudd JHF, Dweck MR, Newby DE. 18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial. Lancet. 2014;383(9918):705–13.

    Article  PubMed  Google Scholar 

  79. Li X, Bauer W, Kreissl MC, Weirather J, Bauer E, Israel I, Richter D, Riehl G, Buck A, Samnick S. Specific somatostatin receptor II expression in arterial plaque: (68)Ga-DOTATATE autoradiographic, immunohistochemical and flow cytometric studies in apoE-deficient mice. Atherosclerosis. 2013;230(1):33–9.

    Article  CAS  PubMed  Google Scholar 

  80. Gaemperli O, Shalhoub J, Owen DRJ, Lamare F, Johansson S, Fouladi N, Davies AH, Rimoldi OE, Camici PG. Imaging intraplaque inflammation in carotid atherosclerosis with 11C-PK11195 positron emission tomography/computed tomography. Eur Heart J. 2012;33(15):1902–10.

    Article  CAS  PubMed  Google Scholar 

  81. Dobrucki LW, and Sinusas AJ. PET and SPECT in cardiovascular molecular imaging. Nat Rev Cardiol. 2010;7(1):38–47.

    Google Scholar 

  82. Schelbert HR. Anatomy and physiology of coronary blood flow. J Nucl Cardiol. 2010;17(4):545–54.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Thackeray JT, deKemp RA, Beanlands RS, DaSilva JN. Insulin restores myocardial presynaptic sympathetic neuronal integrity in insulin-resistant diabetic rats. J Nucl Cardiol Off Publ Am Soc Nucl Cardiol. 2013;20(5):845–56.

    Article  Google Scholar 

  84. Raffel DM, Chen W, Jung Y-W, Jang KS, Gu G, Cozzi NV. Radiotracers for cardiac sympathetic innervation: transport kinetics and binding affinities for the human norepinephrine transporter. Nucl Med Biol. 2013;40(3):331–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Fallavollita JA, Heavey BM, Luisi AJ, Michalek SM, Baldwa S, Mashtare TL, Hutson AD, Haka MS, Sajjad M, Cimato TR, and others. Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy. J Am Coll Cardiol. 2014;63(2):141–9.

    Google Scholar 

  86. Schindler TH, Zhang X-L, Vincenti G, Mhiri L, Lerch R, Schelbert HR. Role of PET in the evaluation and understanding of coronary physiology. J Nucl Cardiol. 2007;14(4):589–603.

    Article  PubMed  PubMed Central  Google Scholar 

  87. Petrou M, Frey KA, Kilbourn MR, Scott PJH, Raffel DM, Bohnen NI, Müller MLTM, Albin RL, Koeppe RA. In vivo imaging of human cholinergic nerve terminals with (−)-5-(18)F-fluoroethoxybenzovesamicol: biodistribution, dosimetry, and tracer kinetic analyses. J Nucl Med Off Publ Soc Nucl Med. 2014;55(3):396–404.

    CAS  Google Scholar 

  88. McMurray JJV, Packer M, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile MR. Angiotensin–neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371(11):993–1004.

    Article  CAS  PubMed  Google Scholar 

  89. Harrison DG, Guzik TJ. Studies of the T-cell angiotensin receptor using cre-lox technology an unan-T-cellpated result. Circ Res. 2012;110(12):1543–5.

    Article  CAS  PubMed  Google Scholar 

  90. Herrero P, Laforest R, Shoghi K, Zhou D, Ewald G, Pfeifer J, Duncavage E, Krupp K, Mach R, Gropler R. Feasibility and dosimetry studies for 18F-NOS as a potential PET radiopharmaceutical for inducible nitric oxide synthase in humans. J Nucl Med Off Publ Soc Nucl Med. 2012;53(6):994–1001.

    CAS  Google Scholar 

  91. Sun N, Lee A, Wu JC. Long term non-invasive imaging of embryonic stem cells using reporter genes. Nat Protoc. 2009;4(8):1192–201.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  92. Tarkin JM, Joshi FR, Rudd JHF. PET imaging of inflammation in atherosclerosis. Nat Rev Cardiol. 2014;11(8):443–57.

    Article  CAS  PubMed  Google Scholar 

  93. National Center for Biotechnology Information (US). Molecular imaging and contrast agent database (MICAD). Bethesda: National Center for Biotechnology Information (US); 2004.

    Google Scholar 

  94. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Airaksinen KEJ, Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang I.-K, Koenig W, Lodder RA, March K, Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr R, Grundy SM, Mehran R, Colombo A, Boerwinkle E, Ballantyne C, Insull W, Schwartz RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland P, Muller J. E, Virmani R, Ridker PM, Zipes DP, Shah PK, Willerson JT. From Vulnerable Plaque to Vulnerable Patient. Circulation. 2003;108(14):1664–72.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, The Ottawa Hospital, 1053 Carling Ave., Ottawa, ON, K1Y 4E9, Canada

    Ran Klein PhD

  2. National Cardiac PET Centre, Cardiac Imaging, The University of Ottawa Heart Institute, 40 Ruskin St., Ottawa, ON, K1Y 4W7, Canada

    Robert A. deKemp PhD, PEng, PPhys

Authors
  1. Ran Klein PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert A. deKemp PhD, PEng, PPhys
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ran Klein PhD .

Editor information

Editors and Affiliations

  1. Medical Biophysics Department of Physics Faculty of Science, Helwan University, Cairo, Egypt

    Magdy M. Khalil

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Klein, R., A. deKemp, R. (2017). Cardiac PET Imaging: Principles and New Developments. In: Khalil, M. (eds) Basic Science of PET Imaging. Springer, Cham. https://doi.org/10.1007/978-3-319-40070-9_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-40070-9_19

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-40068-6

  • Online ISBN: 978-3-319-40070-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation